Hyperfine, Inc.
corporate_fare Company Profile
Hyperfine, Inc. (NASDAQ:HYPR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for HYPR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-18, rated 9/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for HYPR spans 8-K, 10-Q, S-3, DEF 14A.
Recent high-impact activity:
- Hyperfine Faces Nasdaq Delisting After Stock Falls Below $1.00
- Hyperfine Completes Enrollment in Contrast PMR Study, Plans FDA Submission by Year-End
- Hyperfine's Portable MRI Shows 92% Concordance in NEURO PMR Study, Surpasses 3,000 Scans
- FDA Clears Hyperfine's Next Optive AI Software, Adding 3D Imaging to Portable MRI
- Hyperfine Q2 Revenue Jumps 45% to $3.9M, Losses Narrow; Cash Runway Extended Through 2027
Financial Snapshot
Short Interest & Short Volume
11.25 days to coverFINRA reported short interest of 4,236,754 shares in HYPR as of the September 15, 2026 settlement, a 16.1% increase from the prior period — about 11.3 days to cover at its recent average daily volume. On October 2, 2026, 78.5% of HYPR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for HYPR, detected from its recent SEC filings.
Warrant Share Registration · Warrant Exercise Price
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →